Table 2.
ΣFIC vs. Drug Sensitive Bacteria ([H]/[X]) b for Combinations with the Indicated Antibiotics | |||||
Compd | S. aureus ATCC 29213 c | S. aureus SA1199 d | E. coli ATCC 25922 c | ||
Tetracycline | Ciprofloxacin | Tetracycline | |||
A | 0.50 (1/0.0313) | 2 (8/0.16) | 0.38 (1/0.0625) | ||
B | 0.38 (1/0.0156) | 0.75 (4/0.08) | 0.50 (2/0.125) | ||
ΣFIC vs. Drug Resistant Bacteria ([H]/[X]) b for Combinations with the Indicated Antibiotics | |||||
S. aureus AOUC-0915 (LR-MRSa) e | S. aureus SA1199B f | E. coli 288328 (GR-CREc) g | |||
Methicillin h | Linezolid | Ciprofloxacin | Colistin | Gentamicin | |
A | 0.5 < ΣFIC ≤ 0.53 (2/64) | 1.03 (0.125/16) | 0.75 (4/2.5) | 0.31 (1/0.5) | 1.25 (1/128) |
B | 0.5 < ΣFIC ≤ 1.0 (2/1024) | 1.03 (0.125/16) | 0.5 (4/2.5) | 0.28 (2/0.25) | 1.50 (4/128) |
a Cells with cases of synergy are reported in light green. b [H] indicates the concentration of α-hydrazido acid in μg/mL, whereas [X] are the concentrations of the indicated antibiotics in μg/mL. c MICs of tetracycline alone: 0.125 μg/mL for S. aureus ATCC 29213, 0.5 μg/mL for E. coli ATCC 25922. d Ciprofloxacin-susceptible S. aureus SA1199. MIC of ciprofloxacin alone: 0.16 μg/mL. e Linezolid- and methicillin-resistant S. aureus AOUC-0915. MICs of antibiotics alone: 16 μg/mL for linezolid, >1024 μg/mL for methicillin. f Ciprofloxacin-resistant S. aureus SA1199B. MIC of ciprofloxacin alone: 10 μg/mL. g Gentamicin- and colistin-resistant E. coli 288328. MICs: 128 μg/mL for gentamicin, 8 μg/mL for colistin. h The exact MIC for methicillin could not be obtained; thus, the upper and lower limits in reported ranges were calculated using the minimum possible value (2048 μg/mL) and an infinite value, respectively, for the actual methicillin MIC.